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Summary
Current approaches for optogenetic control of transcription do not mimic the activity of 
endogenous transcription factors, which act at numerous sites in the genome in a complex 
interplay with other factors. Optogenetic control of dominant negative versions of endogenous 
transcription factors provides a mechanism for mimicking the natural regulation of gene 
expression. Here we describe opto-DN-CREB, a blue light controlled inhibitor of the transcription 
factor CREB created by fusing the dominant negative inhibitor A-CREB to photoactive yellow 
protein (PYP). A light driven conformational change in PYP prevents coiled-coil formation 
between A-CREB and CREB, thereby activating CREB. Optogenetic control of CREB function 
was characterized in vitro, in HEK293T cells, and in neurons where blue light enabled control of 
expression of the CREB targets NR4A2 and c-Fos. Dominant negative inhibitors exist for 
numerous transcription factors; linking these to optogenetic domains offers a general approach for 
spatiotemporal control of native transcriptional events.
Graphical abstract
*To whom correspondence should be addressed, awoolley@chem.utoronto.ca, Telephone: (416) 978-0675, Fax: (416) 978-8775 . 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Chem Biol. Author manuscript; available in PMC 2016 November 19.
Published in final edited form as:














photo-control; photoactive yellow protein; PYP; optogenetics; photoisomerization; genetically 
encoded; CREB; endogenous; transcription factor; dominant negative
Introduction
The cyclic AMP response element binding protein (CREB) is a transcription factor that 
regulates the expression of genes involved in a diverse set of processes (Impey et al., 2004). 
A variety of extracellular signals trigger CREB activity via the well described cAMP 
signaling cascade (Altarejos and Montminy, 2011; Luo et al., 2012). CREB-dependent gene 
expression plays an important role in the central nervous system, where it regulates neuronal 
survival, memory consolidation, addiction, entrainment of the biological clock, and synaptic 
refinement (Impey et al., 2004). CREB has played a central role of the development of a 
molecular description of how memories are stored in the brain (Kandel, 2012; Zhou et al., 
2009).
CREB activity is tightly regulated in time and space (Cowansage et al., 2013; Han et al., 
2009; Lopez and Fan, 2013; Rogerson et al., 2014; Silva et al., 2009; Wu et al., 2001; Yiu et 
al., 2014; Zhou et al., 2009). For instance, spatiotemporal variations in CREB activity drive 
segmentation and posterior polarity specification in mammalian somitogenesis (Lopez and 
Fan, 2013). Cell to cell variations in CREB activity in the amygdala result in differential 
allocation of specific neurons to a fear memory engram (Cowansage et al., 2013; Han et al., 
2009; Rogerson et al., 2014; Silva et al., 2009; Yiu et al., 2014; Zhou et al., 2009). The 
temporal dynamics of CREB activation may influence whether a fear memory is 
reconsolidated or undergoes extinction (Kim et al., 2014; Mamiya et al., 2009; Monfils et 
al., 2009).
Current optogenetic approaches for controlling transcription rely on targeting transcriptional 
activators or repressors to a specific gene loci chosen for external control (Konermann et al., 
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2013; Liu et al., 2012; Motta-Mena et al., 2014; Niopek et al., 2014; Polstein and Gersbach, 
2015; Shimizu-Sato et al., 2002; Wang et al., 2012). While this approach can provide robust 
control of a given target gene, it does not adequately mimic transcriptional control by 
endogenous factors such as CREB. Approximately ~5000 functional CREB binding sites 
occur in promoter regions of human genes (Zhang et al., 2005) and CREB activation 
typically leads to transcriptional changes in ~100 of these in a given cell type (Altarejos and 
Montminy, 2011; Barco and Marie, 2011). The subset of responsive genes varies 
considerably between cell types (Zhang et al., 2005) and which genes becomes cAMP 
responsive in a given situation depends both on CREB and a family of co-activator proteins 
(Altarejos and Montminy, 2011). An optogenetic approach to probe CREB function, 
therefore needs to target the endogenous transcription factor directly.
A widely used approach for experimentally manipulating the activity of endogenous 
transcription factors with high specificity is the use of dominant negatives (Barco and Marie, 
2011). For example, Vinson and colleagues developed acidic-CREB (A-CREB), a derivative 
of the CREB leucine zipper with an acidic N-terminal extension that traps the positively 
charged basic residues of CREB and prevents binding to DNA (Ahn et al., 1998). A-CREB 
is a highly specific dominant negative against the CREB family and has become a 
commonly used tool for studying CREB biology (Lopez and Fan, 2013; Zhang et al., 2005). 
Analogous dominant negatives have been engineered for other endogenous transcription 
factors including Myc/Max, (Krylov et al., 1997) AP-1, (Olive et al., 1997) C/EBP, 
(Chatterjee et al., 2011) and c-Jun/ATF2 (Yuan et al., 2009).
The challenge of conferring light-switchability on a given protein by fusing an optogenetic 
domain has been met in several cases with relatively little exploration of protein sequence 
space, implying that solutions to this protein engineering problem are relatively easy to find 
(Morgan et al., 2010; Motta-Mena et al., 2014; Strickland et al., 2008; Wu et al., 2009). We 
decided to use photoactive yellow protein (PYP), a small protein that functions in the 
phototactic swimming responses of the bacterium H. halophila, (Kumauchi et al., 2008) to 
confer light sensitivity on A-CREB. The N-terminal sequence of PYP shares rudimentary 
homology with leucine zipper sequences. Among optogenetic domains that have been 
structurally characterized, PYP undergoes relatively large changes in conformation and 
dynamics upon blue light irradiation. In addition, PYP is robust, reversibly folds and 
unfolds, and is tolerant of extensive mutagenesis (Kumar et al., 2013; Philip et al., 2010).
Here we report an A-CREB / PYP hybrid (designated opto-DN-CREB) that acts as a blue-
light dependent CREB dominant negative. Using a combination of biochemical assays, we 
show that opto-DN-CREB provides effective optical control of CREB DNA binding in vitro, 
and of CREB signaling in HEK293T cells and primary cultured neurons.
Results
Protein Design
PYP senses light through the chromophore p-coumaric acid, which is covalently bound to 
the protein. Upon illumination with blue light, the p-coumaric acid chromophore in PYP 
undergoes trans to cis isomerization that leads to the formation of a highly dynamic, molten-
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globule-like, light-adapted state of the protein. The N-terminal cap (residues 1-25), in 
particular, undergoes significant rearrangement (Bernard et al., 2005; Ramachandran et al., 
2011). How this large structural change is conveyed to an attached target protein depends on 
the amino acid sequence of the hybrid. Previously studied hybrids that merged the N-
terminal region of PYP with the leucine zipper of GCN4 exhibited either enhanced or 
diminished target binding upon illumination, depending on the connection between the 
domains (Fan et al., 2011; Morgan et al., 2010; Morgan and Woolley, 2010). Here we used 
the dark state structure of PYP as a starting point to design a chimera in which the N-
terminus of PYP was replaced by an A-CREB coiled-coil-like sequence, with the intent of 
producing a protein that was stable, folded, and underwent a normal photocycle, but had 
potential CREB-bZIP binding properties. To help define the amino acid sequence of the 
chimera, we employed the Rosetta software suite, (Leaver-Fay et al., 2011) which has been 
used extensively to guide the design of well-behaved proteins by avoiding amino acid 
sequences that would form internal cavities, buried polar interactions, or surface-exposed 
hydrophobic patches.
To maintain the interaction specificity of A-CREB toward CREB, it has been previously 
shown that keeping a/d/e/g positions of the coiled-coil is important; in contrast, the b/c/f 
positions can be varied (Grigoryan et al., 2009). The rudimentary sequence similarity 
between the N-terminal segment of PYP and leucine zippers suggested a unique register for 
the chimera (Fig. S1). Using Rosetta (see SI), we identified a new sequence that we 
designated opto-DN-CREB (Fig. 1, S1). This sequence differs from wild-type PYP at 29 
positions, 20 of which are in the N-terminal region; the other residues are on the globular 
part of PYP, facing the N-terminal cap. The sequence is identical to A-CREB at all a/d/e/g 
positions of the coiled-coil, except for two, a Leu→Lys in an e position and a Phe→Leu in a 
g position; neither of these substitutions are expected to alter the interaction specificity (see 
SI)(Fong et al., 2004; Grigoryan et al., 2009; Newman and Keating, 2003). Mutations 
introduced in the globular core were designed to enhance packing or provide partners for 
buried polar sites.
Characterization of opto-DN-CREB in vitro
We expressed opto-DN-CREB in E. coli, purified it to homogeneity using nickel affinity 
followed by gel filtration chromatography, and characterized it using standard biophysical 
methods. The protein exhibited a UV-Vis spectrum characteristic of wild-type PYP (wtPYP) 
and underwent a normal photocycle upon exposure to blue light (Fig. 2a). The stability of 
the dark state of the protein was lower than wtPYP, as measured by its sensitivity to heat 
denaturation and the appearance of a band near 380 nm in the UV-Vis spectrum at elevated 
temperatures – the latter is typical of an altered protein conformation near the chromophore 
binding pocket (Joshi et al., 2009). The addition of an equimolar amount of CREB-bZIP 
stabilized the dark state of opto-DN-CREB according to both these measures, indicating that 
CREB-bZIP and opto-DN-CREB are forming a complex and that this interaction is sensed 
by the chromophore binding core of PYP. Circular dichroism spectra (Fig. 2b) indicated that 
the α-helical content is enhanced in the complex, consistent with coiled-coil formation. The 
addition of CREB-bZIP to opto-DN-CREB also affected the photocycle of opto-DN-CREB 
(Fig. 2c). After removal of the blue light source, opto-DN-CREB underwent thermal 
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relaxation with a half-life of 20 min (at 20oC). The addition of CREB-bZIP produced a 
biexponential relaxation behavior with a faster component (1.4 min half-life) in addition to 
the 20 min process. The fraction of the faster process increased until CREB-bZIP was 
equimolar with opto-DN-CREB, at which point, only the fast relaxation process was 
observed (Fig. 2 c,d). This behavior is consistent with the formation of a tight 1:1 complex 
between opto-DN-CREB and CREB-bZIP. Enhanced thermal relaxation observed after the 
addition of the binding partner means that isomerization of the PYP chromophore and 
CREB-bZIP binding are energetically coupled and indicates that zipper formation lowers the 
barrier for reisomerization to the dark state (Morgan and Woolley, 2010).
We conducted a series of experiments to gain further insight into the structural differences 
between opto-DN-CREB in dark-adapted and blue light irradiated states. At low 
concentrations (< 20 μM), both the light and dark states behaved as monomers in gel 
permeation chromatography (Fig. S2); a monomeric dark state for opto-DN-CREB at these 
lower concentrations was also confirmed by analytical ultracentrifugation (Fig S2). At 
higher concentrations (>100 μM), gel permeation chromatography revealed that opto-DN-
CREB was self-associating (Fig S2). This is unsurprising given that the CREB zipper alone 
has been shown to self-associate at concentrations >100 μM (Santiago-Rivera et al., 1993). 
Notably, the self-association was more pronounced in the dark than under blue light 
illumination, suggesting that the A-CREB leucine zipper domain of opto-DN-CREB is more 
exposed in the dark state. (Fig. S2).
Chemical cross-linking experiments were conducted to test the hypothesis that the leucine 
zipper portion of opto-DN-CREB is more exposed in the dark state. Cross-linking opto-DN-
CREB with bis (sulfosuccinimidyl) suberate (BS3) produced dimers and higher order 
oligomers in the dark, whereas very little cross-linking was observed under blue light (Fig. 
3b). This result is consistent with self-association via a detached and helical conformation of 
the A-CREB domain that is adopted in the dark as depicted in Fig. 3a. Sequestration of the 
A-CREB portion of opto-DN-CREB by the PYP core in the light state reduces self-
association and thereby cross-linking yield. Moreover, interaction with opto-DN CREB 
removes a stabilizing interaction between the A-CREB zipper and the light state, thereby 
enhancing thermal relaxation to the dark state (Fig. 2c,d).
Rosetta simulations using the NMR-derived ensemble for the light state suggested that 
sequestration of A-CREB in the light state could be due to binding of the hydrophobic 
surface of the leucine zipper to a hydrophobic patch on the PYP domain, that is not available 
in the dark state (Fig. S1). Exposure of a hydrophobic surface in the light state of PYP has 
been detected previously by hydrophobic dye-binding studies (Hendriks et al., 2002).
Optical control of CREB-bZIP function in vitro
To assess the ability of opto-DN-CREB to bind CREB-bZIP and prevent CREB-bZIP from 
binding to DNA, we employed an electrophoretic mobility shift assay (EMSA) – a method 
commonly used to detect protein-DNA interactions. Initially, a fluorescently labeled DNA 
oligomer containing the CREB-bZIP (CRE) target binding site was electrophoresed in the 
presence or absence of CREB-bZIP. Mobility of the CREB-bZIP/DNA complex was slowed 
on the gel in comparison to free DNA. The apparent affinity of CREB-bZIP for the CRE 
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oligo was 10 ± 2 nM (Fig. S3). The addition of increasing concentrations of opto-DN-CREB 
inhibited DNA binding by CREB-bZIP. In the dark, opto-DN-CREB exhibited an apparent 
Ki of 25 ± 10 nM (Fig. 4), similar to that of A-CREB alone (Fig. S3). Under blue light this 
inhibition was relieved – the apparent Ki was 500 ± 70 nM, which corresponds to a 20-fold 
increase in comparison to the Ki measured in the dark (Fig. 4). To confirm that the 
interaction with the CREB-bZIP protein was occurring through the leucine zipper of the A-
CREB part of opto-DN-CREB, we tested the behavior of an opto-DN-CREB mutant in 
which two key Leu residues of the leucine zipper were mutated to Gly (Fig. 4, Fig. S1). This 
mutant showed a greatly reduced ability to inhibit CREB-bZIP DNA binding in the dark, 
and an even further reduced ability under blue light.
Collectively our data support the model for opto-DN-CREB activity shown in Fig. 3c. In the 
dark, the A-CREB N-terminal cap of opto-DN-CREB can detach from the PYP core and can 
interact with the CREB-bZIP domain, thereby inhibiting CREB from binding to DNA. Blue 
light leads to sequestration of the A-CREB region of opto-DN-CREB and permits normal 
CREB dimerization and DNA binding
Optogenetic control of CREB signaling in living cells
In the bacterium H. halophila, the p-coumaric acid chromophore of PYP is produced 
biosynthetically from tyrosine through the action of tyrosine ammonia lyase (Kyndt et al., 
2002). Activation of p-coumaric as a CoA thioester for loading onto PYP is catalyzed by p-
coumaric acid ligase (Kyndt et al., 2003). We expected that the functional expression of this 
pair of enzymes in mammalian cells might require significant optimization. Since we were 
primarily interested in assaying the functionality of opto-DN-CREB in cell culture, we opted 
instead to form holo-PYP by adding pcoumaric acid thiophenyl ester to the culture medium. 
The compound is membrane permeable and reacts rapidly and selectively with apo-PYP 
both in vitro and when expressed in cell culture (Hori et al., 2013) and only hydrolyzes 
slowly (τ½ 6 h) in media.
We confirmed the functional reconstitution and photoswitching of the PYP optogenetic 
domain in mammalian cells using a reporter construct consisting of blue fluorescent protein 
(BFP) fused to PYP missing the N-terminal cap (BFP-Δ25PYP; Fig. S4). In the dark state, 
the blue fluorescence of BFP was quenched by PYP (Fig. S4). When PYP was switched to 
its light state, BFP quenching was relieved. Thus, light driven time-dependent changes in 
BFP fluorescence confirmed delivery of the p-coumaric acid thiophenylester and the 
resulting functionality of PYP (Fig. S4).
We systematically assayed the effects of added chromophore concentration and blue light 
intensity on cell viability using MTT assays (Cole et al., 2012) and morphological analysis 
to determine suitable working ranges for these parameters (Fig. S6).
To evaluate the ability of opto-DN-CREB to modulate CREB signaling in living cells we 
assessed CREB-mediated expression of the protein NR4A2 (nuclear receptor subfamily 4, 
group A, member 2), also known as nuclear receptor related 1 protein (NURR1). NR4A2 is 
important for the transcription-dependent consolidation process that converts a short-term 
memory into a long-term memory (Hawk et al., 2012). In addition, NR4A2 plays a key role 
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in the maintenance of dopaminergic pathways in the brain (Sacchetti et al., 2006). NR4A2 is 
an ideal target because it is well established that CREB activation promotes its expression 
(summarized in the hESNET database (http://wanglab.ucsd.edu/star/hESnet/) (http://
wanglab.ucsd.edu/star/hESnet/evidence.jsp?g1=CREB1&g2=NR4A2).
Opto-DN-CREB was expressed in HEK293T cells under control of the constitutive herpes 
simplex virus (HSV) - IE4/5 promoter via transfection with the pHSV vector. 
Approximately 40-48 h after transfection, activated chromophore was added and a subset of 
cells were irradiated with blue light for 60 min. Cells were then treated with forskolin for 2 h 
to activate cAMP signaling, and thereby CREB.
We directly assayed transcript levels of the CREB target gene nurr1 (coding for NR4A2) 
using quantitiative PCR using hprt1 (hypoxanthine-guanine phosphoribosyltransferase) as a 
control (Volpicelli et al., 2012). In control cells, forskolin treatment led to an increase in the 
level of nurr1, as expected (Fig. 5a). This increase occurred whether or not cells were 
irradiated with blue light (Fig. 5a). When cells were transfected with opto-DN-CREB and 
incubated with chromophore in the dark, the forskolin-mediated increase in nurr1 was 
strongly inhibited (Fig. 5a), indicating that opto-DN-CREB blocks CREB signaling in the 
dark. Under blue light irradiation (0.2 mW/cm2), this inhibition by opto-DN-CREB was 
completely relieved (Fig. 5a), exactly as occurred in vitro. These data confirm that opto-DN-
CREB modulates CREB mediated transcription.
Optical modulation of nurr1 transcript levels by opto-DN-CREB are expected to lead to 
changes in levels of the NR4A2 protein. Following the same protocol described above, cells 
were collected, lysed, and the levels of NR4A2 were assayed via Western blotting (Fig. 5b). 
Again, in control cells forskolin treatment led to an increase in the level of NR4A2, as 
expected. This increase occurred whether or not the cells were irradiated with blue light 
(Fig. 5b). When cells were transfected with opto-DN-CREB and incubated with 
chromophore in the dark, NR4A2 levels under basal conditions were decreased and the 
forskolin-mediated increase was strongly inhibited, indicating that opto-DN-CREB blocks 
CREB signaling in the dark. Again, under blue light, this inhibition by opto-DN-CREB was 
completely relieved (Fig. 5b). The effect of opto-DN-CREB inhibition appears more 
pronounced on protein levels than on transcript levels.
To confirm that opto-DN-CREB was inhibiting CREB activity via the same mechanism as 
occurs in vitro, we tested the mutated version of opto-DN-CREB in which two Leu residues 
of the coiled-coil domain were mutated to Gly residues. When cells were transfected with 
this construct (opto-DN-CREB-2Gly), no inhibition of forskolin induced elevation of 
NR4A2 was observed, consistent with the much weaker interaction between opto-DN-
CREB-2Gly and CREB (Fig. S6).
We then examined opto-DN-CREB function in cultured primary cortical neurons (Fig. 5c). 
Replication-deficient HSV viral vector amplicons were generated and used to infect primary 
cortical neurons obtained from E14 mice as previously described (Cole et al., 2012). After 
8-10 days of growth in vitro, neurons were incubated with HSV-opto-DN-CREB viral 
particles. Five hours later the medium was replaced. One day later, cells were loaded with 
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chromophore and then incubated for 1 h in the dark or under blue light before stimulating 
with 30 μM forskolin and 50 mM KCl. Cells were then harvested and processed for Western 
blotting as in the HEK293T cell experiments. In addition to assaying levels of NR4A2, we 
also measured effects on c-Fos, another well studied CREB target gene (Ahn et al., 1998). 
As observed in HEK293T cells, opto-DN-CREB inhibition of forskolin and KCl-mediated 
NR4A2 or c-Fos production is relieved by blue light (Fig. 5c). Collectively, these data 
demonstrate that opto-DNCREB provides a means for blue-light controlled dominant 
negative inhibition of endogenous CREB activity in cultured cells.
Discussion
This work demonstrates that coupling an optogenetic domain to a dominant negative 
inhibitor can produce a light-controlled tool for manipulating the activity of an endogenous 
transcription factor. The dominant negative used here (A-CREB) was designed to bind to the 
bZIP domain of CREB. Numerous analogous dominant negative inhibitors have been 
developed using the same design strategy against both bZIP-type and bHLH-type 
transcription factors (Krylov et al., 1997). In fact, the determinants of interaction specificity 
and affinity of coiled-coils are perhaps the best understood of any protein-protein interaction 
(Fletcher et al., 2013; Negron and Keating, 2014). Keating and colleagues have delineated 
the interaction specificities of the full complement of these factors in human cells (Newman 
and Keating, 2003). Thus, a similar approach to the one taken here could be used to produce 
light-controlled tools for manipulating a variety of endogenous transcription factors.
The choice of PYP as an optogenetic domain was made based on some rudimentary 
sequence homology to coiled-coils but also because PYP is a robust domain that undergoes 
large changes in conformational dynamics upon exposure to blue light. Our results indicate 
that a light state interaction between the PYP core and the leucine zipper of A-CREB is 
important for the function of opto-DNCREB. Rosetta simulations suggest that the light-
adapted PYP core traps the A-CREB sequence folded as an α-helix and that the hydrophobic 
face of the helix interacts with an exposed hydrophobic patch on the PYP core. Rosetta 
simulations using NMR-derived light and dark state ensembles of the PYP domain may be 
used to guide the design of other light-switchable dominant negative inhibitors. Our 
experience here, and those of others, indicate that Rosetta protein design software is a 
powerful tool to guide the choice of sequences that produce folded, soluble proteins 
(Kaufmann et al., 2010). Based on the studies presented here, it appears that linking a 
binding sequence to PYP is likely to yield a functional switch in other cases as well. From 
the starting point of a folded, switchable protein with some affinity for its target, directed 
evolution or screening approaches could also be used to find improved switches (Guntas et 
al., 2014; Mazumder et al., 2015).
We have shown that opto-DN-CREB acts as a blue light-dependent modulator of CREB 
signaling in living neurons. Demonstration of blue light controlled activity on validated 
CREB targets implies that opto-DN-CREB could be used directly for experiments aimed at 
probing effects of spatiotemporal differences in CREB activity in cell culture or brain slice 
preparations. For example, the precise timing of CREB activation for chemically-induced 
long term potentiation (LTP) could be investigated in neuronal cell cultures. Incubation of 
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cells in the dark would produce inactive opto-DNCREB / CREB complexes, similar to what 
occurs with A-CREB alone in neurons (Ahn et al., 1998). Blue light irradiation could then 
be used to release active CREB from this complex in targeted cells. Since conversion to the 
light state of opto-DN-CREB occurs in seconds at typical light intensities used for imaging 
(Fig. S4), the time frame at which CREB becomes functional in cells would then depend 
only on the time taken for free CREB to assemble into transcriptionally active complexes. If 
desired, opto-DN-CREB inhibition could be restored rapidly by a UV light pulse, or allowed 
to reoccur via thermal relaxation (in minutes per Fig. S4). As with channelrhodopsins, opto-
DN-CREB, ideally when co-expressed with the genes required for chromophore 
biosynthesis, could also permit modulation of CREB activity in freely moving animals via 
delivery of blue light through fiber optic cables (Aravanis et al., 2007). This modality would 
enable an unprecedented level of spatiotemporal dissection of CREB mediated transcription 
in processes such as long term memory formation.
Experimental procedures
Design of opto-DN-CREB as guided by Rosetta modeling. Details of the sequence 
alignment performed and the overall design procedure are provided in the Supplemental 
Information (SI). To predict the specificity of coiled coil formation, we used the “bZIP 
Coiled-Coil Scoring Form” server (http://compbio.cs.princeton.edu/bzip/).
In vitro analysis of opto-DN-CREB
Opto-DN-CREB, the CREB bZIP domain and the A-CREB dominant negative were 
overexpressed and purified from bacteria using Ni-NTA affinity and size exclusion 
chromatography. Full details are provided in the SI. Spectral and kinetic measurements of 
optical switching of purified opto-DN-CREB were acquired using a PE Lambda 35 
spectrophotometer with a Peltier temperature control unit. Circular dichroism was performed 
using an Olis RSM 1000 circular dichroism spectrophotometer. Self-association of purified 
opto-DN-CREB was assessed by size exclusion chromatography using a Superdex 75 
10/300 GL column (GE Healthcare) running in tris-acetate-EDTA, 100 mM NaCl buffer 
(pH 7.5) at various protein concentrations and under dark and blue light irradiated 
conditions. Chemical cross-linking of purified opto-DN-CREB was carried out at a protein 
concentration of 250 μM in sodium phosphate buffer, pH 7.0. Solutions of dark-adapted or 
blue-light-irradiated opto-DN-CREB (~10 mW/cm2) were incubated in at 25oC in the 
presence of bis(sulfosuccinimidyl) suberate (BS3)(ThermoScientific) for 30 min. The 
reactions were quenched by adding 200 mM lysine. Samples were then analyzed by SDS-
PAGE (10% polyacrylamide, 1 M Tris, 10% (w/v) glycerol).
Electrophilic Mobility Shift Assays (EMSA) of Opto-DN-CREB function
Binding of the CREB bZIP domain to a 28 base-pair target DNA duplex containing the CRE 
site was assayed using EMSA analysis as detailed in the SI. Protein and DNA samples were 
incubated then electrophoresed on an 8% polyacrylamide gel. The gels were scanned with a 
red laser on Pharos FX® plus molecular imager (Bio-Rad) and the images were recorded 
using QualityOne software (Bio-Rad). The extent of CREB bZIP CRE binding was 
quantified by analysis with Image Lab® software (Bio-Rad). Using Igor Pro software, three 
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sets of data were averaged and fit to the Hill equation to determine the apparent Kd, i.e., the 
concentration of protein required for 50% binding to the CRE site. Inhibtion of CREB-bZIP 
binding by A-CREB or by opto-DN-CREB was assayed in a simailr manner. To assay under 
blue light irradiation, the sample preparation, incubation, and gel run were performed under 
cycles of 450 nm illumination composed of 3 minutes of irradiation followed by 2 minutes 
in the dark. An array of Luxeon III Star LED Royal Blue LEDS (455 nm), (overall ~50 
mW/cm2), was used as the light source
Functional analysis of opto-DN-CREB in cells
The cDNAs for mammalian expression of A-CREB and opto-DN-CREB were synthesized 
(Biobasic, Inc.) and subcloned into the vector pHSV. Viability of transfected cells was 
assessed using Trypan blue assays, MTT assays and morpholgical analysis as descrined in 
the SI. Optical switching in of PYP in living HEK293 cells was initially assessed using a 
reporter construct in which BFP was fused to the N-terminus of 25-PYP via a flexible linker 
(Fig. S4). Excitation of BFP at 400 nm leads to fluorescence emission at 450 nm. Emission 
is partially quenched by dark-adapted PYP. The excitation wavelength also causes 
isomerization of PYP to its light state. This state does not quench BFP so effectively, 
leading to a time dependent increase in fluorescence emission when dark-adapted BFP-Δ25-
PYP is exposed to blue light.
Modulation of Cre activity by opto-DN-CREB: qPCR
To examine modulation of Cre-mediated transcription by opto-DN-CREB in HEK 293T 
cells, quantitative PCR was performed to detect transcript levels of nurr1 (NR4A2) and 
hprt1 (hypoxanthine-guanine phosphoribosyltransferase) as a control. Full details are 
provided in the SI. HEK cells were grown in 96-well plates and transfected with either 
pHSV-opto-DN-CREB. Approximately 40-48 hrs after transfection, cells were washed and 
chromophore was added. All samples were incubated for 15 min in the dark and a subset of 
plates were subsequently moved to an incubator with blue light illumination (0.2 mW/cm2) 
for 60 min. Cells under both dark and illuminated conditions were then treated with 
forskolin (50 μM) for 2 hrs in serum free media. Media was aspirated and cells were flash 
frozen prior to RNA isolation. cDNA was made using a high capacity cDNA reverse 
transcriptase kit (Life Technologies Inc., cat#4374966). Quantitative real-time PCR (qPCR) 
was performed using the Evagreen mastermix (ABM, #mastermix-S) in a Biorad CFX96 
real time detection system.
Modulation of Cre activity by opto-DN-CREB: Western blots
To assay protein levels of NR4A2, HEK293T cells were grown in 6 cm dishes to 80% 
confluency in DMEM with 10% FBS. Each dish was then transfected with 4 g of either 
pHSV-ACREB, pHSV-opto-DN-CREB or empty vector. Cells under both dark and 
illuminated conditions were then treated with forskolin (50 μM) for 2 h in serum free media 
before collection and lysis for Western blotting. To examine light dependent inhibition of 
CRE activity by opto-DN-CREB in neurons, replication-deficient Herpes virus amplicons 
were generated and used to infect primary cortical neurons. After 8-10 days of growth in 
vitro, neurons were incubated with HSV-ACREB-PYP or HSV-GFP (control vector) viral 
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particles. Five hours later the medium was replaced. One day later, cells were loaded with 
chromophore (0.1 mg/mL) and then incubated for 1 hr in the dark or under light illumination 
(0.2 mW/cm2) before stimulating with 30 μM forskolin and 50 mM KCl for 2h at 37oC. 
Cells were then harvested and processed for Western blotting. For Western blotting, lysates 
were subjected to polyacrylamide gel electrophoresis and electroblotted onto PVDF 
membranes. Membranes were incubated with antibodies against NR4A2 (rabbit, 1:1000; 
Sigma-Aldrich, Cat# N6413) and β-actin (rabbit, 1:1000; Cell Signaling Inc., Cat# 4967) as 
a loading control. With neurons, blotting was also performed to detect protein levels of c-
Fos (1:1000; rabbit polyclonal, sc-52, Santa Cruz). For quantification, optical densities of 
bands associated with NR4A2 or β-actin were measured using Image J software (NIH). 
NR4A2 levels were measured relative to β-actin levels in each lane and then normalized to 
controls indicated in each blot.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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CREB (cAMP response element-binding protein), a member of the bZIP family of 
cellular transcription factors, plays central roles in numerous cellular processes and has 
been a focus for studies on the molecular basis of learning and memory. Current 
optogenetic tools are not suitable for controlling spatial and temporal variations the 
activity of endogenous transcription factors like CREB. Here we describe the design and 
characterization a new type of optogenetic tool - opto-DN-CREB - a blue light controlled 
dominant negative inhibitor of CREB that can permit fine spatial and temporal control of 
CREB binding to cAMP response elements.
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• Specific dominant negative (DN) inhibitors exist for many transcription factors.
• Fusing DNs to optogenetic domains permits optical control of native 
transcription.
• Opto-DN-CREB was created by fusing a DN for CREB to the optogenetic 
domain PYP.
• Optical control of CREB function in vitro, in HEK cells, and in cultured 
neurons.
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Figure 1. Models of CREB bound to DNA and CREB inhibited by opto-DN-CREB
(a) The bZIP domain of CREB (cyan ribbon) forms a dimeric parallel coiled-coil when 
bound to the DNA (solid surface) (PDBID: 1DH3). (b) A model of the designed protein 
opto-DN-CREB (shown in surface representation) bound to a single CREB-bZIP domain 
(cyan ribbon). Residues in the A-CREB-like N-terminal hybrid region of opto-DN-CREB 
that are critical for coiled-coil formation with the CREB zipper are colored cyan. 
Interactions between the acidic extension of A-CREB and the basic region of CREB are not 
modeled.
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Figure 2. Biophysical characterization of opto-DNA-CREB
(a) UV-Vis spectra of opto-DN-CREB immediately after blue light irradiation (dotted line) 
then at 2 min intervals during the process of dark adaptation (gray lines). The dark-adapted 
spectrum is the solid black line. (b) CD spectra of opto-DN CREB and CREB-bZIP 
separately and together. The arithmetic sum of the separate spectra is also shown and 
exhibits significantly less negative ellipticity than the spectra obtained from the opto-DN 
CREB /CREB-bZIP mixture. (c) Time courses of thermal relaxation measured at 350 nm in 
the absence of CREB-bZIP (i), with 0.5 equivalents of CREB-bZIP (ii) and with 1.1 eq. of 
CREB-bZIP (iii). Solid lines are experimental data and dotted lines are single exponential 
fits to these data. In (ii), two components to the relaxation rate are clearly visible. (d) 
Relative fractions of fast and slow time constants extracted from global analysis of thermal 
relaxation data as a function of the concentration of added CREB-bZIP. The opto-DN-
CREB concentration is 10 μM.
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Figure 3. Blue light dependent exposure of the zipper domain of opto-DN-CREB
(a) Models of opto-DN-CREB derived from Rosetta design simulations. The PYP core is 
shown as a yellow surface. The A-CREB N-terminal cap is shown as a cyan ribbon. In the 
dark-adapted state (top), the A-CREB cap can be detached and helical. The detached helix 
can lead to a self-associated state that is trapped by chemical cross-linking. In the light state 
(lower model), the PYP core traps the A-CREB portion via an exposed hydrophobic patch. 
This state is shown schematically having the A-CREB N-terminal cap hidden. (b) Chemical 
cross-linking of opto-DN-CREB. SDS-PAGE gel showing oligomers (dimer, trimer, etc.) 
formed by crosslinking dark-adapted opto-DN-CREB (250 μM) with BS3 (5 mM). These 
species are formed to a much lesser extent when the reaction is carried out under blue light. 
(c) Schematic showing light dependent inhibition of CREB DNA binding by opto-DN-
CREB. In the dark, the detached helical region A-CREB N-terminal cap can interact with 
the CREB-bZIP domain, thereby inhibiting full length CREB from binding to DNA. Full 
length CREB also contains glutamine rich domains (Q1, Q2) and a kinase inducible domain 
(KID). Blue light leads to sequestration of the A CREB region of opto-DN-CREB and 
permits normal CREB dimerization, DNA binding, and transcriptional regulation.
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Figure 4. EMSA analysis of opto-DN-CREB inhibition of CREB-bZIP DNA binding
(a) Increasing concentrations (indicated by the black wedge) of opto-DN-CREB (dark-
adapted) prevent formation of the CREB-bZIP/CRE DNA complex (controls – free DNA, + 
CREB-bZIP bound DNA). (b) Much larger concentrations of opto-DN-CREB are required 
to inhibit CREB-bZIP DNA binding when the system is illuminated with blue light. 
Inhibition curves derived from 3 replicates of these data are shown at right (see SI for 
fitting). Solid dark line (dark-adapted, Ki 25 ± 10 nM), solid blue line (blue light 
illuminated, Ki 500 ± 70 nM), dashed line (thermally relaxed after blue light irradiation, Ki 
30 ± 10 nM). (c) EMSA analysis using opto-DN-CREB (2Gly) under dark-adapted 
conditions and under blue light (d) shows much weaker inhibition. Solid dark line (dark-
adapted, Ki 550 ± 90 nM), solid blue line (blue light illuminated, Ki 6 ± 1 μM).
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(a) Forskolin treatment of HEK293T cells produces an increase in nurr1 that is blocked by 
opto-DN-CREB in the dark, but not under blue light. Changes in levels of nurr1 were 
determined by qPCR. Cells were transfected with control (empty) vector (empty bars) or 
with the opto-DN-CREB vector (filled bars). Data from cells illuminated with blue light are 
shown as blue bars; data from dark-adapted cells are shown as black bars. In control cells, 
forskolin treatment caused a large increase in nurr1 transcript levels (the hprt1 transcript 
was used as an internal control) (* p<0.05 using Student's t-test (unpaired) between dark and 
light condtions). In cells transfected with opto-DN-CREB and incubated in the dark, the 
forskolin-mediated increase seen in nurr1 levels seen with controls was prevented. Under 
blue light illumination (0.2 mW/cm2), this inhibition by opto-DN-CREB was relieved. Blue 
light alone did not affect levels of nurr1 under basal conditions or after forskolin 
stimulation.
(b) Forskolin treatment of HEK293T cells produces an increase in NR4A2 that is blocked by 
opto-DN-CREB in the dark, but not under blue light. Changes in levels of NR4A2 were 
determined by Western blots (see Fig. S6 for blots). Cells were transfected with control 
(empty) vector (empty bars) or with the opto-DN-CREB vector (filled bars). Data from cells 
illuminated with blue light are shown as blue bars; data from dark-adapted cells are shown 
as black bars. In cells transfected with opto-DN CREB and incubated in the dark, NR4A2 
levels under basal conditions were decreased and the forskolin-mediated increase seen in 
controls was prevented. Under blue light illumination, this inhibition by opto-DN-CREB 
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was relieved (* p<0.05 using Student's t-test (unpaired) between dark and light condtions). 
Blue light alone did not affect cellular levels of NR4A2 under basal conditions or after 
forskolin stimulation.
(c) Opto-DN-CREB inhibits forskolin and KCl mediated NR4A2 or c-Fos production in 
primary cortical neurons. This inhibition is relieved by blue light. Cells were treated with 
HSV-opto-DN CREB viral particles and exposed to blue light or dark-adapted (blue bars 
and black bars respectively). CREB signaling was stimulated in a subset of cells (stim) with 
forskolin and KCl. Cells were harvested and Western blots for NR4A2, c-Fos and β-actin 
(loading control) (Fig. S6) were quantified for cells without stimulation (unstim) and with 
stimulation (stim) (*, significant difference between S and US, p<0.05 using Student's t-test 
(unpaired), n=8-10 for each condition). With a control vector, increases in response to 
forskolin and KCl stimulation were observed as expected in both dark and under light 
illumination (not shown).
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